Nembutal capsule Abbott discontinued its Nembutal model of pentobarbital capsules in 1999, largely changed because of the benzodiazepine family of drugs. Phenobarbital could decrease the action of some prescription drugs by growing the rate of metabolism by induction of drug-metabolising enzymes